Skip to main content
Medium-chain acyl-coA dehydrogenase (MCAD) deficiency is an inherited disorder of fatty acid metabolism caused by mutations in the MCAD gene. Individuals with MCAD are at risk for hypoglycemia during times of illness or prolonged fasting. Diagnosis is made using blood acylcarnitine profile, urine organic acids and mutation analysis. MCAD deficiency is estimated to affected 1/10 000 – 1/15 000 individuals and is included in the Washington State newborn screening program.
Seattle Children’s provides healthcare for the special needs of children regardless
of race, sex, creed, ethnicity or disability. Financial assistance for medically
necessary services is based on family income and hospital resources and is provided
to children under age 21 whose primary residence is in Washington, Alaska, Montana
Seattle Children’s Hospital, Research